ROBBIE PHILLIPS: Open Payments
NPI 1710730585 · ALTAMONTE SPG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 42 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $197 · 2025 $894
Food & beverage: $862Education: $31
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $199 |
| ABBVIE INC. | 11 | $142 |
| Corium, LLC | 7 | $120 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| Bausch Health US, LLC | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, Azstarys, Auvelity, INGREZZA, REXULTI, APLENZIN, COBENFY.
Industry payments across FL — which companies pay providers there.
